دوا کے تعاملات
Cyclophosphamide + Idarubicin
شدت: شدید
Cyclophosphamide and Idarubicin: major interaction.
آخری تازہ کاری
صرف صحت کے پیشہ ور افراد کے لیے — محض حوالے کے طور پر۔ یہ صفحہ مختصر خلاصہ ہے، طبی مشورہ نہیں، اور سرکاری لیبل یا طبی فیصلے کا متبادل نہیں۔ تجویز یا فراہمی سے پہلے ہمیشہ تصدیق کریں۔
اس صفحے کا طبی مواد صرف انگریزی میں دستیاب ہے۔
خلاصہ
Both drugs are cardiotoxic, and giving them together may increase the risk of cardiomyopathy and heart failure beyond that of idarubicin alone. Additive myelosuppression is also expected.
اس تعامل کا آسان لفظوں میں مطلب
Cyclophosphamide and Idarubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for.
Cyclophosphamide belongs to Oncology; Idarubicin belongs to Oncology.
ایسا کیوں ہوتا ہے
Additive cardiotoxicity, possibly via increased formation of toxic anthracycline metabolites in myocardium, plus additive myelosuppression.
کیا کرنا ہے
Assess left ventricular function before and during treatment, and keep cumulative anthracycline dose within recommended limits. Monitor blood counts and consider cardioprotective measures in high-risk patients.
فارماسسٹ سے کیا پوچھیں
- Does the benefit of taking both outweigh the risk in my case?
- Do I need any blood test, ECG or other check while on both?
- What early warning signs should I watch for, and what should I do if they appear?
Pro+ اراکین کے لیے
پورا صفحہ کھولیں
Cyclophosphamide اور Idarubicin کے لیے مکمل طبی انتظام کی رہنمائی، اضافی نوٹس، شواہد کی تفصیل اور پورے نسخے کا تعامل چیکر کھولنے کے لیے اکاؤنٹ بنائیں اور Pro+ ٹرائل شروع کریں۔
- Full clinical management advice
- Additional notes
- Evidence detail
- Interaction checker for a whole prescription
ویب پر 7 دن تک Pro+ مفت آزمائیں۔ کارڈ کی ضرورت نہیں۔
Cyclophosphamide کے دیگر تعاملات
Idarubicin کے دیگر تعاملات
اکثر پوچھے جانے والے سوالات
Can I take Cyclophosphamide with Idarubicin?
MediHelp rates the interaction as major. Cyclophosphamide and Idarubicin can interact in a way that may be serious. Using them together is sometimes necessary, but it needs a deliberate decision by the prescriber, a plan for monitoring, and clear advice on the warning signs to watch for. Both drugs are cardiotoxic, and giving them together may increase the risk of cardiomyopathy and heart failure beyond that of idarubicin alone. Additive myelosuppression is also expected.
How serious is the interaction between Cyclophosphamide and Idarubicin?
MediHelp rates it major, on a four-level scale (minor, moderate, major, contraindicated) based on published labels and references. What to do, in brief: Assess left ventricular function before and during treatment, and keep cumulative anthracycline dose within recommended limits. Monitor blood counts and consider cardioprotective measures in high-risk patients.
What other medicines interact with Cyclophosphamide?
MediHelp also lists interactions of Cyclophosphamide with, for example, Adenovirus types 4 and 7 live, Belatacept, Bendamustine. The full list is on the Cyclophosphamide page.
MediHelp ایپ میں مکمل مونوگراف، خوراک اور تعامل چیکر
MediHelp ایپ میں مکمل حوالہ کھولیں، متعدد ادویات کے تعاملات جانچیں اور خوراک کے ٹولز استعمال کریں۔
